Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
IDNA vs FBT
Shared holdings
6
IDNA covered by FBT
20.81%
FBT covered by IDNA
20.81%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
IDNA (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| BlackRock Cash Funds: Institutional, SL Agency Shares | 14.21% | |
| MODERNA INC | 5.05% | |
| Bayer Aktiengesellschaft | 4.33% | |
| REVOLUTION MEDICINES INC | 3.86% | |
| TAKEDA PHARMACEU | 3.80% | |
| BIONTECH SE ADR | 3.75% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 3.73% | |
| IPSEN | 3.65% | |
| MERCK & CO | 3.51% | |
| GSK PLC | 3.41% | |
| REGENERON PHARMACEUTICALS INC | 3.27% | |
| VERTEX PHARMACEUTICALS INC | 3.27% | |
| GENMAB AS | 3.26% | |
| INCYTE CORP | 3.10% | |
| Sanofi SA | 3.02% | |
| EXELIXIS INC | 2.96% | |
| ARCELLX INC | 2.75% | |
| IDEAYA BIOSCIENCES | 2.51% | |
| CARIS LIFE SCIENCES INC | 2.49% | |
| TWIST BIOSCIENCE CORP | 2.23% | |
| IMMUNITYBIO INC | 1.93% | |
| ONO PHARMA | 1.66% | |
| ARCUS BIOSCIENCES INC | 1.47% | |
| CRISPR Therapeutics A.G. Series A | 1.44% | |
| NOVAVAX INC | 1.22% | |
| NUVATION BIO INC | 1.17% | |
| CORVUS PHARMACEUTICALS INC | 1.11% | |
| IOVANCE BIOTHERAPEUTICS INC | 0.79% | |
| AbCellera Biologics Inc COM | 0.78% | |
| GENFLEET THERAPEUTICS SHANGHAI INC | 0.71% | |
| JANUX THERAPEUTICS INC | 0.69% | |
| CYTOMX THERAPEUTICS INC | 0.68% | |
| VIR BIOTECHNOLOGY INC | 0.65% | |
| KURA ONCOLOGY INC | 0.64% | |
| VALNEVA SE | 0.62% | |
| ABCLON INC | 0.62% | |
| RIGEL PHARMACEUTICALS INC | 0.57% | |
| PACIFIC BIOSCIENES OF CALI INC | 0.57% | |
| SUNSHINE LAKE PHARMA CO LTD | 0.54% | |
| ALVOTECH SA | 0.53% | |
| PERSONALIS INC | 0.46% | |
| INTELLIA THERAPEUTICS INC | 0.46% | |
| OCUGEN INC | 0.42% | |
| VERASTEM INC | 0.37% | |
| GINKGO BIOWORKS HOLDINGS INC | 0.35% | |
| SHANGHAI HENLIUS BIOTECH INC H | 0.32% | |
| DESIGN THERAPEUTICS INC | 0.30% | |
| XENCOR INC | 0.26% | |
| GUANGZHOU INNOGEN PHARMACEUTICAL GROUP CO LTD | 0.24% | |
| PRIME MEDICINE INC | 0.11% |
FBT (March 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 5.26% | |
| UNITED THERAPEUTICS CORP DEL | 4.36% | |
| ALKERMES PLC | 4.23% | |
| GILEAD SCIENCES INC | 4.09% | |
| AXSOME THERAPEUTICS INC | 3.88% | |
| AMGEN INC | 3.83% | |
| CORCEPT THERAPEUTICS INC | 3.82% | |
| KRYSTAL BIOTECH INC | 3.51% | |
| BIOGEN INC | 3.47% | |
| EXELIXIS INC | 3.46% | |
| NEUROCRINE BIOSCIENCES INC | 3.44% | |
| REGENERON PHARMACEUTICALS INC | 3.44% | |
| VERTEX PHARMACEUTICALS INC | 3.42% | |
| BIOMARIN PHARMACEUTICAL INC | 3.40% | |
| ARGENX SE SPONSORED ADR | 3.29% | |
| SAREPTA THERAPEUTICS INC | 3.24% | |
| HALOZYME THERAPEUTICS INC | 3.17% | |
| BIONTECH SE ADR | 3.16% | |
| INCYTE CORP | 3.13% | |
| BEONE MEDICINES LTD ADR | 3.12% | |
| ILLUMINA INC | 3.10% | |
| NATERA INC | 3.03% | |
| ACADIA PHARMACEUTICALS INC | 2.95% | |
| ALNYLAM PHARMACEUTICALS INC | 2.95% | |
| BIO-TECHNE CORP | 2.82% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 2.78% | |
| VERACYTE INC | 2.72% | |
| REPLIGEN CORP | 2.51% | |
| BRUKER CORP | 2.35% | |
| NEOGENOMICS INC | 2.00% | |
| DREY-GVT CSH-I | 0.06% | |
| DAIWA CAPITAL MARKETS AMERICA INC | 0.01% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.